Published in Br J Surg on March 01, 2007
Standardization of Surgery on the Pancreatic Cancer | NCT00679913
Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med (2010) 4.13
Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol (2011) 1.65
The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials. Langenbecks Arch Surg (2009) 1.33
Ductal pancreatic adenocarcinoma. Dtsch Arztebl Int (2014) 1.14
The role of radiotherapy in multimodal treatment of pancreatic carcinoma. Radiat Oncol (2010) 1.09
The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704. Int J Radiat Oncol Biol Phys (2010) 1.05
Posterior versus standard approach in pancreatoduodenectomy: a case-match study. Langenbecks Arch Surg (2009) 0.96
Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens. HPB (Oxford) (2013) 0.95
Surgical strategies for treatment of malignant pancreatic tumors: extended, standard or local surgery? World J Surg Oncol (2008) 0.92
Laparoscopic staging and surgical treatment of pancreatic cancer. N Am J Med Sci (2013) 0.87
Pancreaticoduodenectomy for pancreatic cancer: the Verona experience. Surg Today (2011) 0.85
Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data. Am J Clin Oncol (2014) 0.84
Pancreatic resections for advanced M1-pancreatic carcinoma: the value of synchronous metastasectomy. HPB Surg (2010) 0.84
Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis. World J Gastroenterol (2015) 0.84
The Study Centre of the German Surgical Society: current trials and results. Langenbecks Arch Surg (2012) 0.84
Extended lymphadenectomy in patients with pancreatic cancer is debatable. World J Surg (2013) 0.83
Current status and progress of pancreatic cancer in China. World J Gastroenterol (2015) 0.83
S-1 vs. gemcitabine as an adjuvant therapy after surgical resection for ductal adenocarcinoma of the pancreas. World J Surg (2014) 0.83
Long-term survival after resection of pancreatic ductal adenocarcinoma with para-aortic lymph node metastasis: case report. World J Surg Oncol (2013) 0.82
Surgery for pancreatic carcinoma: state of the art. Indian J Surg (2011) 0.81
Second-look operation for unresectable pancreatic ductal adenocarcinoma at a high-volume center. Ann Surg Oncol (2007) 0.81
Surgical resection strategies for locally advanced pancreatic cancer. Langenbecks Arch Surg (2015) 0.81
Extended pancreatic resections and lymphadenectomy: An appraisal of the current evidence. World J Gastrointest Surg (2010) 0.80
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up. Langenbecks Arch Surg (2015) 0.79
Current state of surgical management of pancreatic cancer. Cancers (Basel) (2011) 0.79
A meta-analysis of extended versus standard lymphadenectomy in patients undergoing pancreatoduodenectomy for pancreatic adenocarcinoma. HPB (Oxford) (2015) 0.79
Adequacy of lymph node retrieval for ampullary cancer and its association with improved staging and survival. World J Surg (2013) 0.78
Current surgical management of pancreatic cancer. J Gastrointest Oncol (2011) 0.78
Mesopancreas: A boundless structure, namely the rationale for dissection of the paraaortic area in pancreaticoduodenectomy for pancreatic head carcinoma. World J Gastroenterol (2015) 0.78
Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile? World J Surg Oncol (2014) 0.77
Surgical treatment concepts for patients with pancreatic cancer in Germany--results from a national survey conducted among members of the "Chirurgische Arbeitsgemeinschaft Onkologie" (CAO) and the "Arbeitsgemeinschaft Internistische Onkologie" (AIO) of the Germany Cancer Society (DKG). Langenbecks Arch Surg (2010) 0.77
Pancreaticoduodenectomy: outcomes in a low-volume, specialised Hepato Pancreato Biliary unit. World J Surg (2014) 0.77
Does the Ileal Brake Contribute to Delayed Gastric Emptying After Pancreatoduodenectomy? Dig Dis Sci (2016) 0.77
Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement. Langenbecks Arch Surg (2016) 0.77
No-touch isolation techniques for pancreatic cancer. Surg Today (2016) 0.76
The lymphatic system and pancreatic cancer. Cancer Lett (2015) 0.76
The Pancreas: Causes for Malabsorption. Viszeralmedizin (2014) 0.76
Prognostic value of the lymph node ratio after resection of periampullary carcinomas. HPB (Oxford) (2012) 0.76
CA724 is a novel factor for predicting the unresectability in pancreatic adenocarcinoma. Int J Clin Exp Pathol (2015) 0.75
Palliative interventional and surgical therapy for unresectable pancreatic cancer. Cancers (Basel) (2011) 0.75
Extended pancreatectomy for pancreatic cancers. Indian J Surg (2010) 0.75
Pancreatic Cancer: Current Options for Diagnosis, Staging and Therapeutic Management. Gastrointest Tumors (2013) 0.75
Identification of an N staging system that predicts oncologic outcome in resected left-sided pancreatic cancer. Medicine (Baltimore) (2016) 0.75
Continuous suturing with two anterior layers reduces post-operative complications and hospitalization time in pancreaticoenterostomy. BMC Gastroenterol (2016) 0.75
Preoperative defining system for pancreatic head cancer considering surgical resection. World J Gastroenterol (2016) 0.75
Pathophysiology after pancreaticoduodenectomy. World J Gastroenterol (2015) 0.75
Mesopancreas in pancreatic cancer: where do we stand - review of literature. Indian J Surg Oncol (2014) 0.75
Nodal sampling in pancreaticoduodenectomy: does it change our management? HPB (Oxford) (2007) 0.75
MicroRNA Expression in a Readily Accessible Common Hepatic Artery Lymph Node Predicts Time to Pancreatic Cancer Recurrence Postresection. J Gastrointest Surg (2016) 0.75
Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy. J Gastrointest Oncol (2016) 0.75
Para-aortic lymph node metastases in pancreatic cancer should not be considered a watershed for curative resection. Sci Rep (2017) 0.75
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. Int J Mol Sci (2017) 0.75
Reconsideration about the aggressive surgery for resectable pancreatic cancer: a focus on real pathological portosplenomesenteric venous invasion. Langenbecks Arch Surg (2015) 0.75
Meta-analysis of the efficacies of extended and standard pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas. World J Surg (2014) 0.75
Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study. J Cancer Res Clin Oncol (2016) 0.75
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet (2001) 5.75
Randomized clinical trial on the effect of coffee on postoperative ileus following elective colectomy. Br J Surg (2012) 4.01
Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg (2004) 3.90
Fewer adhesions induced by laparoscopic surgery? Surg Endosc (2004) 3.11
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg (2001) 2.94
IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol (2000) 2.93
Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas (2004) 2.85
Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg (2000) 2.73
Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene (1997) 2.58
Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest (1992) 2.54
Pancreatic fistula after pancreatic head resection. Br J Surg (2000) 2.44
Use of accurate diagnostic criteria may increase incidence of stercoral perforation of the colon. Dis Colon Rectum (2000) 2.41
Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg (1992) 2.38
Incisional hernia rate 3 years after midline laparotomy. Br J Surg (2013) 2.37
Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut (2008) 2.36
Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg (1995) 2.36
Molecular characterisation of pancreatic ductal adenocarcinoma in patients under 40. J Clin Pathol (2006) 2.33
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer (2005) 2.32
Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res (2001) 2.24
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest (1998) 2.22
Systematic review and meta-analysis of technique for closure of the pancreatic remnant after distal pancreatectomy. Br J Surg (2005) 2.18
Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res (1993) 2.15
Retroperitoneal endoscopic neurectomy for nerve entrapment after hernia repair. Br J Surg (1997) 2.12
Missed diaphragmatic injuries and their long-term sequelae. J Trauma (1998) 2.09
Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion (2000) 2.09
Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res (1993) 2.08
The problem of the poor control arm in surgical randomized controlled trials. Br J Surg (2012) 2.08
Incidence, risk factors, and prevention of biliary tract injuries during laparoscopic cholecystectomy in Switzerland. World J Surg (2001) 2.07
Circulatory and respiratory complications of carbon dioxide insufflation. Dig Surg (2004) 2.06
Neuroimmune appendicitis. Lancet (1999) 2.05
Overexpression of HER2/neu oncogene in human pancreatic carcinoma. Hum Pathol (1993) 2.05
Management of acute pancreatitis: from surgery to interventional intensive care. Gut (2005) 2.02
[The diagnostic value of the amino acid absorption test in detection of a disorder of exocrine pancreatic function]. Z Gastroenterol (1992) 2.02
Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer (1999) 1.99
Carcinoid of the ampulla of Vater. Clinical characteristics and morphologic features. Cancer (1994) 1.97
Late mortality in patients with severe acute pancreatitis. Br J Surg (2001) 1.92
High coincidence of Mirizzi syndrome and gallbladder carcinoma. Surgery (1997) 1.89
Effect of preoperative biliary drainage on surgical outcome after pancreatoduodenectomy. Am J Surg (2001) 1.87
Robot-assisted abdominal surgery. Br J Surg (2004) 1.85
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer (2008) 1.84
Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer. Br J Surg (2011) 1.82
Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer (1999) 1.81
ESPEN guidelines on nutrition in acute pancreatitis. European Society of Parenteral and Enteral Nutrition. Clin Nutr (2002) 1.75
Robot-assisted versus conventional laparoscopic fundoplication: short-term outcome of a pilot randomized controlled trial. Surg Endosc (2007) 1.75
Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res (1997) 1.74
Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas. Br J Surg (2010) 1.73
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer (2009) 1.69
Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res (2001) 1.67
Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer (1995) 1.67
The role of infection in acute pancreatitis. Gut (1999) 1.66
Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. Hum Mol Genet (2006) 1.63
The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene (1999) 1.63
Laparoscopic restorative proctocolectomy. Br J Surg (2005) 1.60
Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci (2003) 1.60
KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res (1996) 1.59
Clinical significance of liver ischaemia after pancreatic resection. Br J Surg (2011) 1.59
The suprapubic approach for laparoscopic appendectomy. Surg Endosc (2001) 1.56
Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res (2001) 1.55
Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma. Biochem Biophys Res Commun (1998) 1.52
Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis. Am J Surg (1995) 1.52
High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease. Gut (2005) 1.51
Endoscopic retroperitoneal neurectomy for chronic pain after groin surgery. Br J Surg (2009) 1.50
A pancreatic cancer-specific expression profile. Oncogene (1996) 1.50
Randomized clinical trial of stapler versus clamp-crushing transection in elective liver resection. Br J Surg (2014) 1.50
Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg (2008) 1.50
Immune cell infiltration and growth-associated protein 43 expression correlate with pain in chronic pancreatitis. Gastroenterology (1997) 1.49
Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma. Br J Cancer (1997) 1.47
Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut (2001) 1.46